Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar - CNBC
Source:CNBC
Eli Lilly’s full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit declining as much as 13% this year.
Related Articles
Man uses $4,999 autonomous snow blower to clear his driveway during winter storm: 'I'm inside sipping a coffee' - Business Insider
Forget robotaxis — a man and his robo-snow blower were the envy of X during the weekend’s …
Google offers buyouts to staff in its business unit who aren't 'all in' - Business Insider
Google’s chief business officer Philipp Schindler announces voluntary exit packages for select …
Trump’s Fed Chair Search Is Becoming Hunt for Elusive Unicorn - Bloomberg
President Donald Trump’s search for a new Federal Reserve chair is becoming a hunt for an elusive …
Microsoft Gave FBI Keys To Unlock Encrypted Data, Exposing Major Privacy Flaw - Forbes
The tech giant said providing encryption keys was a standard response to a court order. But …